Neurocrine (NBIX) - Yalpi foyda normasi

NBIX (Neurocrine Biosciences Inc) - kompaniyaning tovar belgisi

Neurocrine Biosciences (NBIX) neyromeditsina innovatsiyalari bilan shug'ullanadi. Savdo marjalari operatsion rentabellikni namoyish etadi, bunda 96.40 ushbu ko'rsatkichning joriy hajmini ko'rsatadi. Biznes inqilobiy dori vositalari uchun qattiq raqobat sharoitida qat'iy patent himoyasiga tayanadi. Biroq, yagona flagman mahsulotga bog'liqlik xatarlarni yuzaga keltiradi. Bemorlarning yuqori sodiqligi va FDA qo'llab-quvvatlashi barqaror daromad oqimini ta'minlaydi.

NBIX: Neurocrine Biosciences, Inc. Yalpi marja 04.07.2022 - 20.11.2026

neurocrine.com (NBIX) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi ko'rsatkichlari:
- pul mablag'lari va pul oqimlari statistikasi:
Neurocrine Biosciences brend mahsuloti

Himoya aktivlari pul oqimlarining bozor tebranishlariga chidamliligi asosida tanlanadi. Neurocrine Biosciences (NBIX) xomashyo ta'minoti zanjiridagi uzilishlar xavf-xatarlarga qaramay, o'z dori vositalariga bo'lgan barqaror talab tufayli ushbu tamoyilga amal qiladi. Valdlar xarajatlarini tushumdan ayirish orqali hisoblanadigan yalpi marja ishlab chiqarish samaradorligini o'lchaydi, bu esa 96.40 qiymatida aks etgan. Ushbu yalpi foyda foizini tahlil qilish operatsion rentabellikni va aktiv uchun haddan tashqari ko'p to'lov qilish xavfini baholash imkonini beradi.

Toʻgʻridan-toʻgʻri raqobatchilar

Yalpi foyda bo'yicha rentabellik Biogen Corp|RGC (Regencell Corp) - Yalpi marja|AXSM: Yalpi foyda normasi|Yalpi rentabellik acadia-pharm.com (ACAD)|Yalpi marja Xenon Pharmaceuticals (XENE)|Yalpi rentabellik Viking Therapeutics VKTX|Yalpi foyda normasi SUPN|CPRX - Yalpi rentabellik|Yalpi foyda marjasi Denali Therapeutics|HRMY: Yalpi marja|Biohaven - Yalpi foyda normasi|Yalpi foyda bo'yicha rentabellik AMLX|Trevi Therapeutics, Inc. (TRVI) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi foyda bo'yicha rentabellik PRAX (Praxis Medicines)|Anavex Corp - Sotuvning yalpi rentabelligi|Yalpi rentabellik CeriBell CBLL|Yalpi foyda bo'yicha sotuv rentabelligi Prothena Biosciences (PRTA)|ALEC: Yalpi foyda bo'yicha rentabellik|ANNX - Yalpi marja|Omeros Corp. (OMER) - Yalpi rentabellik|Yalpi foyda marjasi Neurogene Inc. (NGNE)|Yalpi foyda bo'yicha rentabellik ACIU|Yalpi rentabellik VYGR|Yalpi rentabellik Neumora (NMRA)|SCLX - Yalpi foyda marjasi|Yalpi marja TVGN (Tevogen Bio Holdings Inc.)|Yalpi foyda normasi ACOG|Cognition Therapeutics Inc. - Yalpi marja|IKT - Yalpi marja|SAVA: Yalpi marja|Assertio Holdings, Inc. - Yalpi foyda normasi|COYA (Coya) - Yalpi marja|Sotuvning yalpi rentabelligi VTGN (Vistagen Therapeutics)|Yalpi rentabellik Ovid Rx (OVID)|Acumen Pharmaceuticals - Sotuvning yalpi rentabelligi|Yalpi rentabellik CervoMed, Inc. CRVO|Yalpi marja Alterity Therapeutics ATHE|CLNN: Yalpi foyda bo'yicha rentabellik|PEPG (pepgen.com) - Sotuvning yalpi rentabelligi|Jupiter Neurosciences Inc (JUNS) - Yalpi rentabellik|Relmada Therapeutics - Yalpi foyda normasi|ANVS (Annovis Bio Inc) - Yalpi marja|GRCE: Yalpi foyda normasi|Yalpi rentabellik Firefly Neuroscience Inc (AIFF)|KLTO (ANEW Medical) - Yalpi foyda normasi|Yalpi rentabellik neurosense-tx.com NRSN|Reviva Pharmaceuticals Holdings, Inc. (RVPH) - Yalpi foyda marjasi|MTVA: Yalpi foyda bo'yicha rentabellik|NeurAxis, Inc (NRXS) - Yalpi foyda bo'yicha rentabellik|HSDT: Yalpi marja|PASG - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi rentabellik Neuphoria Therapeutics, Inc.|Yalpi rentabellik NERV|Yalpi marja ATHA|ADXN (Addex Therapeutics Ltd) - Yalpi foyda normasi|Yalpi rentabellik alzamend.com ALZN|Yalpi foyda bo'yicha sotuv rentabelligi Cyclerion Therapeutics (CYCN)|Protagenic - Yalpi marja|Yalpi foyda normasi KTTA (Pasithea Therapeutics Corp)|CRGT: Yalpi marja|Avenue Therapeutics Inc. (ATXI) - Yalpi marja|BCLI (BrainStorm Cell Therapeutics Inc.) - Yalpi marja|Yalpi marja Cara Therapeutics Inc|Yalpi rentabellik Chromocell Therapeutics (CHRO)|Yalpi foyda koeffitsiyenti ELYM|Yalpi rentabellik Intra-Cellular ITCI|LBPH: Sotuvning yalpi rentabelligi|MRNS - Yalpi rentabellik|NKGen Biotech, Inc. (NKGN) - Yalpi foyda bo'yicha rentabellik|neurobopharma.com (NRBO) - Yalpi rentabellik|SAGE: Yalpi foyda koeffitsiyenti|Yalpi rentabellik Synaptogenix, Inc.|Yalpi rentabellik TRVN|Yalpi marja VIGL|Yalpi marja anewmeds.com (WENA)|Yalpi marja CERE (cerevel.com)